Sign in to view content

Do scheduling issues impact commonly needed testing for patients with moderate diabetic retinopathy with macular edema?

Leonard H. Ginsburg, MD

Video
Published 2019

Related

Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use
Blake A. Cooper, MD MPH
Updates from the Field
2022
High-Dose Anti-VEGF: Cross-Trial Analysis of Different Doses and Antagonists for the Treatment of Diabetic Macular Edema
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
On Demand Cases, Courses, and Papers
2019
Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2017

Category: Practice Management - Coding - Computers

See more